rabbit polyclonal anti-e2f5 (Thermo Fisher)
Structured Review

Rabbit Polyclonal Anti E2f5, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal anti-e2f5/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Transcriptional Regulation of Mammary Alveolar Proliferation and Differentiation during Early Pregnancy"
Article Title: Transcriptional Regulation of Mammary Alveolar Proliferation and Differentiation during Early Pregnancy
Journal: bioRxiv
doi: 10.1101/2024.11.27.625731
Figure Legend Snippet: (A) Normalized expression of E2F5 in whole mammary glands at different stages of development: virgin, pregnancy day 6 (P6), pregnancy day 18 (P18), lactation day 1 (L1), and lactation day 10 (L10). (B) Normalized expression of E2F5 in basal and luminal cells isolated from mammary glands at different stages: virgin, pregnancy day 18.5 (Preg day 18.5), and lactation day 2 (Lac day 2). (C) Venn diagram showing overlap between E2f5 CUT&RUN target genes and differentially expressed genes in early pregnancy (virgin vs. P6). (D) Normalized expression of several up-regulated E2f5 target genes known to be associated with proliferation and differentiation during pregnancy. (E) Volcano plot of differentially expressed genes between virgin and P6, with E2f5 targets labeled.
Techniques Used: Expressing, Isolation, Labeling
Figure Legend Snippet: Paired mammary wholemounts (A) and H&E staining (B) from 12 weeks virgin adult E2F5 CKO, day 5 pregnant E2F5 f/f and day 5 pregnant E2F5 CKO mice shown an impairment on alveoli formation during pregnancy on mice lacking E2F5 in mammary epithelium. (C) PCNA expression in pregnant mice shows reduced proliferative activity in E2F5 CKO mice. (D) Alveoli quantification shown reduced proliferative activity in mice lacking E2F5 in mammary epithelium (p=0.0025).
Techniques Used: Staining, Expressing, Activity Assay
Figure Legend Snippet: (A) Early pregnancy in E2F5 CKO females undergoing a second gestation shows reduced number of alveoli in comparison with E2F5 f/f group. Upon day 14 of pregnancy, E2F5 CKO females shows non phenotypic differences in comparison with control groups. (B) Matched histological sections shown evidence of early but no late pregnancy defects in E2F5 CKO females.
Techniques Used: Comparison, Control
Figure Legend Snippet: (A) Principal component analysis (PCA) plot showing clustering of CUT&RUN data based on chromatin occupancy for E2F5, H3K4me3, H3K27me3, and IgG across two replicates each. (B) De novo motif discovery using MEME-ChIP revealed a motif that is distinct from the known E2F consensus motif. (C) Motif similarity analysis using Tomtom identified overlap between the discovered E2F5 motif and the known E2F consensus motif. (D) Integrative Genomics Viewer (IGV) tracks showing E2F5 and H3K4me3 occupancy at the promoters of known cell cycle regulatory genes, including CDKN2A, CDKN2B, CDKN2C, CDK4, and CCND1, supporting the role of E2F5 in regulating genes involved in cellular proliferation.
Techniques Used:
Figure Legend Snippet: (A) Integrative Genomics Viewer (IGV) tracks showing E2F5, H3K4me3, and IgG CUT&RUN signal at the STAT6 promoter in HC11 mouse mammary epithelial cells. (B) Luciferase reporter assay in 293T cells showing that E2F5 represses STAT6 promoter activity. (C) STAT6 promoter-luciferase reporter assay of MCF7 cells treated with vehicle or R5020 and co-transfected with CMV-HA-E2F5 or CMV-Neo-Bam (empty vector).
Techniques Used: Luciferase, Reporter Assay, Activity Assay, Transfection, Plasmid Preparation
Figure Legend Snippet: In the absence of progesterone signaling, E2F5 binds to the STAT6 promoter and represses its transcription (left panel). Upon activation of PR, E2F5-mediated repression is relieved, leading to transcriptional activation of STAT6. This could occur either by displacement of E2F5 from the STAT6 promoter or through cooperation between E2F5 and activated PR at the STAT6 promoter (right panel).
Techniques Used: Activation Assay